COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals® Announces Third Quarter 2017 Financial and Operating Results

07/11/2017 - 22:24

– PROMISE 2 pivotal trial completed enrollment and top-line data on track for 1H18 – – Eptinezumab Biologics License Application (BLA) submission on track for 2H18 – – Conference call scheduled for 5 p.m. ET today – [...]

REVA Medical Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:15

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported financial results for [...]

Akcea to Present at Stifel 2017 Healthcare Conference

07/11/2017 - 22:15

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

07/11/2017 - 22:08

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings

07/11/2017 - 22:05

Revenue increased 307% and 87%, respectively, compared to the three and nine month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz., Nov. 07, 2017 (GLOBE NEWSWIRE [...]

Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:05

AUSTIN, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ: AGLE ) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat [...]

Global Blood Therapeutics Announces Participation at the Stifel 2017 Healthcare Conference

07/11/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the Stifel 2017 Healthcare Conference in New York City on [...]

Novavax Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:05

GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced its financial results for the third quarter and nine months ended September 30, 2017. Third Quarter Achievements: [...]

Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results

07/11/2017 - 22:05

Total Revenues of $190.2 Million Up 7 Percent GAAP Diluted EPS of $1.15 and Adjusted EPS of $0.26 Up 13 Percent GeneSight ® Demonstrates Statistical Significance for Response and Remission in Prospective Study SALT LAKE [...]

miRagen Therapeutics to Participate in Four Investor Conferences in November

07/11/2017 - 22:05

BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ) a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]

TESARO Announces Third-Quarter 2017 Operating Results

07/11/2017 - 22:05

ZEJULA ® was the most prescribed PARP inhibitor in U.S. with Q3 net sales of $39.4 million Positive CHMP opinion issued for ZEJULA in E.U.; commercial launch anticipated to begin by year-end Expansion of niraparib [...]

BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:05

Company Posts Strong Growth with Integration Ahead of Schedule Reports Record Quarterly Revenue and Adjusted EBITDA MALVERN, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile [...]

Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update

07/11/2017 - 22:05

Net cash used in operating and investing activities was $18.3 million in the third quarter and $94.8 million for the first nine months of 2017; quarter-end cash and restricted cash position of $460.1 million, provides [...]

TRACON Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

07/11/2017 - 22:05

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Bellicum Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:05

HOUSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update

07/11/2017 - 22:05

Affirms plans to release Acuitas® AMR Gene Panel in the first quarter of 2018 Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) [...]

Kura Oncology Reports Third Quarter 2017 Financial Results and Provides Corporate Update

07/11/2017 - 22:05

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (Nasdaq: KURA ) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported third quarter [...]

AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017

07/11/2017 - 22:05

GAINESVILLE, Fla., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene [...]

Editas Medicine Announces Third Quarter 2017 Results and Update

07/11/2017 - 22:03

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today reported financial results for the third quarter ended September 30, 2017, and provided [...]